--- title: "The innovative drug sector opened high again, Thalys has achieved a 4-day consecutive limit up" type: "News" locale: "en" url: "https://longbridge.com/en/news/247227850.md" description: "The innovative drug sector opened high again, with Thalys hitting a 4-day limit up, T&K and Zhongyuan Union opening 6% higher, and Cosunter, Sinobioway Medicine, and Changchun High-tech all opening higher" datetime: "2025-07-04T01:28:31.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/247227850.md) - [en](https://longbridge.com/en/news/247227850.md) - [zh-HK](https://longbridge.com/zh-HK/news/247227850.md) --- # The innovative drug sector opened high again, Thalys has achieved a 4-day consecutive limit up The innovative drug sector opened high again, with Thalys achieving a four-day consecutive rise, T&K and Zhongyuan Union opening 6% higher, and Cosunter, Sinobioway Medicine, and Changchun High-tech all opening high ### Related Stocks - [301263.CN](https://longbridge.com/en/quote/301263.CN.md) - [300436.CN](https://longbridge.com/en/quote/300436.CN.md) - [002581.CN](https://longbridge.com/en/quote/002581.CN.md) - [603716.CN](https://longbridge.com/en/quote/603716.CN.md) ## Related News & Research - [11:05 ETThe Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund](https://longbridge.com/en/news/287088476.md) - [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md) - [20:38 ETHyundai Bioscience Discloses XAFTY®'s IC50 Data for Ebola--"Secured Scientific Evidence for Immediate Treatment"](https://longbridge.com/en/news/287135394.md) - [858 Therapeutics Announces Initial Data from First-in-Human Phase 1/2 Trial of PARG Inhibitor ETX-19477 to be Presented at 2026 ASCO Annual Meeting](https://longbridge.com/en/news/287275117.md) - [10:15 ETLEVEL Sleep Protab Improved Sleep Quality and Next-Morning Outcomes in Independent 29-Day Study](https://longbridge.com/en/news/287236615.md)